References

Chagas' disease

10.1056/nejmra1410150 · 2015 · External reference

10.1016/j.idc.2012.03.002

10.1016/j.idc.2012.03.002 · External reference

Chagas disease in Spain, the United States and other non-endemic countries

10.1016/j.actatropica.2009.07.019 · 2010 · External reference

Chagas disease in Australia and New Zealand: risks and needs for public health interventions

10.1111/tmi.12235 · 2014 · External reference

Unresolved reference

External reference

Increased mortality attributed to Chagas disease: a systematic review and meta-analysis

10.1186/s13071-016-1315-x · 2016 · External reference

Mortality due to Chagas disease in Brazil from 1979 to 2009: trends and regional differences

10.3855/jidc.2459 · 2012 · External reference

10.1371/journal.pntd.0000114

10.1371/journal.pntd.0000114 · External reference

Global economic burden of Chagas disease: a computational simulation model

10.1016/s1473-3099(13)70002-1 · 2013 · External reference

Frequency of the congenital transmission of Trypanosoma cruzi: a systematic review and meta-analysis

10.1111/1471-0528.12396 · 2014 · External reference

Oral transmission of Chagas' disease

2011 · External reference

Alternative transmission mechanisms of Trypanosoma cruzi in Brazil and proposals for their prevention

2011 · External reference

The main sceneries of Chagas disease transmission. The vectors, blood and oral transmissions — a comprehensive review

10.1590/0074-0276140362 · 2015 · External reference

10.1007/978-1-4419-9206-2_10

10.1007/978-1-4419-9206-2_10 · 2003 · External reference

Reactivation of Chagas disease: implications for global health

10.1016/j.pt.2015.06.006 · 2015 · External reference

Mode of death on Chagas heart disease: comparison with other etiologies. A subanalysis of the REMADHE prospective trial

10.1371/journal.pntd.0002176 · 2013 · External reference

The present situation, challenges, and perspectives regarding the production and utilization of effective drugs against human Chagas disease

10.1590/0037-8682-0248-2013 · 2014 · External reference

Toxic profile of benznidazole in patients with chronic Chagas disease: risk factors and comparison of the product from two different manufacturers

10.1128/aac.04660-14 · 2015 · External reference

Safety profile of nifurtimox and treatment interruption for chronic Chagas disease in Colombian adults

10.4269/ajtmh.15-0256 · 2015 · External reference

Nova tripanozomiase humana: Estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem

10.1590/s0074-02761909000200008 · 1909 · External reference

10.1155/2014/912965

10.1155/2014/912965 · External reference

Autoimmune pathogenesis of Chagas heart disease: looking back, looking ahead

10.1016/j.ajpath.2014.12.023 · 2015 · External reference

Parasite persistence correlates with disease severity and localization in chronic Chagas' disease

10.1086/314889 · 1999 · External reference

The role of parasite persistence in pathogenesis of Chagas heart disease

10.1111/j.1365-3024.2009.01108.x · 2009 · External reference

10.1111/cmi.12584

10.1111/cmi.12584 · External reference

The indeterminate form of human chronic Chagas' disease: a clinical epidemiological review

10.1590/s0037-86821989000300007 · 1989 · External reference

Morbidity in Chagas' disease. IV. Longitudinal study of 10years in Pains and Iguatama, Minas Gerais, Brazil

10.1590/s0074-02761985000100011 · 1985 · External reference

Cardiac morbidity and mortality due to Chagas' disease: prospective electrocardiographic study of a Brazilian community

10.1161/01.cir.75.6.1140 · 1987 · External reference

Population pharmacokinetic study of benznidazole in pediatric Chagas disease suggests efficacy despite lower plasma concentrations than in adults

10.1371/journal.pntd.0002907 · 2014 · External reference

Long-term follow-up of a patient since the acute phase of Chagas disease (South American trypanosomiasis): further treatment and cure of the infection

10.1590/0037-8682-0073-2015 · 2015 · External reference

Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial

10.7326/0003-4819-144-10-200605160-00006 · 2006 · External reference

Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up

10.1016/0002-8703(94)90521-5 · 1994 · External reference

Evaluation and treatment of Chagas disease in the United States: a systematic review

10.1001/jama.298.18.2171 · 2007 · External reference

A serological, parasitological and clinical evaluation of untreated Chagas disease patients and those treated with benznidazole before and thirteen years after intervention

10.1590/0074-0276130122 · 2013 · External reference

Course of chronic Trypanosoma cruzi infection after treatment based on parasitological and serological tests: a systematic review of follow-up studies

10.1371/journal.pone.0139363 · 2015 · External reference

10.1038/srep35351

10.1038/srep35351 · External reference

Lineage analysis of circulating Trypanosoma cruzi parasites and their association with clinical forms of Chagas disease in Bolivia

10.1371/journal.pntd.0000687 · 2010 · External reference

10.1590/s0074-02762004000100001

10.1590/s0074-02762004000100001 · External reference

10.1586/14787210.2015.1056158

10.1586/14787210.2015.1056158 · External reference

Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection

2014 · External reference

Trypanocide treatment of women infected with Trypanosoma cruzi and its effect on preventing congenital Chagas

10.1371/journal.pntd.0003312 · 2014 · External reference

International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients

10.1371/journal.pntd.0000931 · 2011 · External reference

Analytical validation of quantitative real-time PCR methods for quantification of Trypanosoma cruzi DNA in blood samples from Chagas disease patients

10.1016/j.jmoldx.2015.04.010 · 2015 · External reference

Antibody levels correlate with detection of Trypanosoma cruzi DNA by sensitive polymerase chain reaction assays in seropositive blood donors and possible resolution of infection over time

10.1111/j.1537-2995.2012.03902.x · 2013 · External reference

Biological markers for evaluating therapeutic efficacy in Chagas disease, a systematic review

10.1586/14787210.2014.899150 · 2014 · External reference

Evaluating Chagas disease progression and cure through blood-derived biomarkers: a systematic review

10.1586/14787210.2013.824718 · 2013 · External reference

Serum biomarkers predictive of cure in Chagas disease patients after nifurtimox treatment

10.1186/1471-2334-14-302 · 2014 · External reference

10.1371/journal.pone.0079629

10.1371/journal.pone.0079629 · External reference

10.1371/journal.pntd.0001587

10.1371/journal.pntd.0001587 · External reference

Ten-year incidence of Chagas cardiomyopathy among asymptomatic Trypanosoma cruzi-seropositive former blood donors

10.1161/circulationaha.112.123612 · 2013 · External reference

10.1056/nejmoa1313122

10.1056/nejmoa1313122 · External reference

Unresolved reference

External reference

Unresolved reference

External reference

Randomized trial of benznidazole for chronic Chagas' cardiomyopathy

10.1056/nejmoa1507574 · 2015 · External reference

Clinical candidate VT-1161's antiparasitic effect in vitro, activity in a murine model of Chagas disease, and structural characterization in complex with the target enzyme CYP51 from Trypanosoma cruzi

10.1128/aac.02287-15 · 2015 · External reference

10.1021/jm500448u

10.1021/jm500448u · External reference

10.1177/1087057114550585

10.1177/1087057114550585 · External reference

Antitrypanosomal treatment with benznidazole is superior to posaconazole regimens in mouse models of Chagas disease

10.1128/aac.00689-15 · 2015 · External reference

10.1128/aac.00520-15

10.1128/aac.00520-15 · External reference

Translational challenges of animal models in Chagas disease drug development: a review

10.2147/dddt.s90208 · 2015 · External reference

Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions

10.1007/s00436-008-0992-6 · 2008 · External reference

Persistence of PCR positive tissue in benznidazole-treated mice with negative blood parasitological and serological tests in dual infections with Trypanosoma cruzi stocks from different genotypes

10.1093/jac/dkn092 · 2008 · External reference

Impact of benznidazole on infection course in mice experimentally infected with Trypanosoma cruzi I, II, and IV

10.4269/ajtmh.13-0690 · 2015 · External reference

10.1038/nature19339

10.1038/nature19339 · External reference

10.1371/journal.ppat.1005058

10.1371/journal.ppat.1005058 · External reference

Chagas disease has not been controlled in Ecuador

10.1371/journal.pone.0158145 · 2016 · External reference

Barriers to treatment access for Chagas disease in Mexico

10.1371/journal.pntd.0002488 · 2013 · External reference